Blood platelets in human essential hypertension.

Area of Science:

• Cardiovascular Medicine
• Hematology
• Pharmacology

Background:

• Essential hypertension is associated with cardiovascular complications, including thrombosis.
• Platelet function is crucial in hemostasis and thrombosis.
• Altered platelet characteristics may contribute to the pathophysiology of hypertension.

Purpose of the Study:

• To investigate the specific modifications in blood platelet profiles of patients with essential hypertension.
• To assess platelet sensitivity to aggregating stimuli and in vivo activation markers.
• To correlate platelet changes with the degree of blood pressure elevation.

Main Methods:

• Analysis of platelet aggregation, adhesion, and calcium signaling in response to various agonists (ADP, arachidonic acid, thrombin, adrenaline).
• Measurement of alpha 2-adrenergic receptor density and serotonin/noradrenaline content and uptake/efflux.
• Assessment of in vivo activation markers (Beta-thromboglobulin) and platelet lifespan.
• Evaluation of platelet cyclooxygenase and thromboxane synthetase activity.

Main Results:

• Hypertensive patients exhibited increased platelet sensitivity to aggregation stimuli and enhanced in vivo activation.
• Key findings include increased alpha 2-adrenergic receptor density, facilitated adhesion/aggregation, heightened calcium responses, reduced serotonin, and accelerated platelet turnover.
• These platelet alterations were observed to varying degrees and not always correlated with blood pressure levels.
• Platelet cyclooxygenase and thromboxane synthetase activities remained within the normal range.

Conclusions:

• Blood platelets in essential hypertension show a pro-thrombotic and activated phenotype.
• Specific platelet modifications, including receptor density and signaling pathways, are implicated in hypertension.
• The observed platelet changes contribute to understanding the complex mechanisms underlying hypertension and associated thrombotic risks.